Author(s):
Harshit Narang, Gitesh Chandra, Anish Chandy
Email(s):
Email ID Not Available
DOI:
10.52711/0975-4377.2026.00020 
Address:
Harshit Narang1, Gitesh Chandra1, Anish Chandy2*
1Students, Chouksey School of Pharmacy, CEC, Bilaspur, CG, India.
2Associate Professor, Chouksey School of Pharmacy, CEC, Bilaspur, CG, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 2,
Year - 2026
ABSTRACT:
Hypertension remains a major global health challenge affecting approximately 1.4 billion adults worldwide, with significant cardiovascular morbidity and mortality. Atenolol, a cardioselective ß1-adrenergic receptor blocker, is widely prescribed for hypertension management but suffers from limitations including incomplete oral absorption (50% bioavailability), extensive first-pass hepatic metabolism, and short biological half-life (6-7 hours) necessitating frequent dosing. This research article presents a comprehensive investigation into the formulation, optimization, and characterization of mucoadhesive buccal patches containing atenolol for sustained drug delivery and improved therapeutic efficacy in hypertension management. The buccal patches were formulated using various mucoadhesive polymers including hydroxypropyl methylcellulose (HPMC K4M), sodium alginate, carbopol 934P, and sodium carboxymethyl cellulose (NaCMC) by solvent casting technique. Comprehensive physicochemical characterization was performed including weight variation, thickness uniformity, folding endurance, tensile strength, surface pH, moisture content, moisture absorption capacity, drug content uniformity, mucoadhesive strength, and in vitro drug release studies. Fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC) confirmed absence of drug-polymer interactions. The optimized formulation exhibited excellent mucoadhesive properties, controlled drug release kinetics following Higuchi model, and favorable physicochemical characteristics. Results indicate that atenolol buccal patches represent a promising alternative drug delivery system capable of bypassing first-pass metabolism, enhancing bioavailability, reducing dosing frequency, and improving patient compliance in chronic hypertension management.
Cite this article:
Harshit Narang, Gitesh Chandra, Anish Chandy. Formulation and Characterization of Atenolol Buccal Patch for the effective Management of Hypertension. Research Journal of Pharmaceutical Dosage Forms and Technology. 2026; 18(2):128-6. doi: 10.52711/0975-4377.2026.00020
Cite(Electronic):
Harshit Narang, Gitesh Chandra, Anish Chandy. Formulation and Characterization of Atenolol Buccal Patch for the effective Management of Hypertension. Research Journal of Pharmaceutical Dosage Forms and Technology. 2026; 18(2):128-6. doi: 10.52711/0975-4377.2026.00020 Available on: https://www.rjpdft.com/AbstractView.aspx?PID=2026-18-2-6
REFERENCES:
1. World Health Organization. (2024). Hypertension - Key facts. WHO Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/hypertension
2. National Center for Health Statistics. (2024). Hypertension Prevalence Among Adults Aged 18 and Over: United States, 2021-2023. NCHS Data Brief No. 511. Centers for Disease Control and Prevention.
3. National Center for Biotechnology Information. (2024). Atenolol. In StatPearls. StatPearls Publishing.
4. Mason, W. D., Winer, N., Kochak, G., Cohen, I., and Bell, R. Kinetics and absolute bioavailability of atenolol. Clinical Pharmacology and Therapeutics. 1979; 25(4): 408-415.
5. Consensus Academic Search. (2021). Atenolol Pharmacokinetics.
6. Shaikh, R., Raj Singh, T. R., Garland, M. J., Woolfson, A. D., and Donnelly, R. F. Mucoadhesive drug delivery systems. Journal of Pharmacy and Bioallied Sciences. 2011; 3(1): 89-100.
7. Sudhakar, Y., Kuotsu, K., and Bandyopadhyay, A. K. Buccal bioadhesive drug delivery - A promising option for orally less efficient drugs. Journal of Controlled Release. 2006; 114(1): 15-40.
8. Boddupalli, B. M., Mohammed, Z. N., Nath, R. A., and Banji, D. Mucoadhesive drug delivery system: An overview. Journal of Advanced Pharmaceutical Technology and Research. 2010; 1(4): 381-387.
9. Khairnar, G. A., Sayyad, S. F., Baviskar, D. T., Jain, D. K., and Raut, R. W. Mucoadhesive polymers for buccal drug delivery system. Asian Journal of Pharmaceutical Research and Development. 2014; 2(3): 35-44.
10. Patel, V. M., Prajapati, B. G., and Patel, M. M. Formulation and evaluation of buccal patches for delivery of atenolol. Pharmaceutical Development and Technology. 2010; 15(5): 508-515.
11. Kaur, A., and Kaur, G. Mucoadhesive buccal patches based on interpolymer complexes of chitosan-pectin for delivery of carvedilol. Saudi Pharmaceutical Journal. 2011; 20(1): 21-27.
12. Meldrum OW, Yakubov GE, Gartaula G, McGuckin MA, Gidley MJ. Mucoadhesive functionality of cell wall structures from fruits and grains: Electrostatic and polymer network interactions mediated by soluble dietary polysaccharides. Scientific Reports. 2017 Nov 17; 7(1): 15794.